Ledger.Open graph →
SEC Form D · filed April 17, 2024

Exsilio Therapeutics Inc

Offering
$85.0M
Sold
$38.8M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Alex Harding · New York, NYDirectorAaron Nelson · Sheridan, WYDirectorAlex Harding · New York, NYDirectorRoy Amariglio · New York, NYExec · DirectorStephen Squinto · HANOVER, NHDirectorStephen Squinto · Woodbridge, CTDirectorHenry Chen · Sunnyvale, CADirectorAaron Nelson · Sheridan, WYDirectorDylan Morris · Palo Alto, CADirectorRoy Amariglio · New York, NYExec · DirectorDylan Morris · San Fransicso, CADirectorAnat Nursella · New York, NYExecTal Zaks, M.D., Ph.D · New York, NYDirectorTal Zaks, M.D., Ph.D · New York, NYDirectorAnat Nursella · New York, NYExecHenry Chen · Mountain View, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗